In our study, we individually knocked down YTHDF1/2/3 and IGF2BP1/2/3 in two NPC cell lines and observed that only knockdown of IGF2BP2 significantly inhibited the protein level of ANKRD22 (Figure 5A and Figure S6A). This evidence concerns the gene IGF2BP1 and nasopharyngeal carcinoma.